tiprankstipranks
Trending News
More News >
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Income Statement

Compare
543 Followers

Artelo Biosciences Income Statement

Last quarter (Q3 2025), Artelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Artelo Biosciences's net income was $-3.12M. See Artelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 10.11M$ 9.93M$ 10.29M$ 7.44M$ 4.69M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 500.00
EBITDA
$ -10.11M$ -9.93M$ -10.08M$ -7.44M$ -4.69M
Operating Income
$ -10.11M$ -9.93M$ -10.29M$ -7.44M$ -4.69M
Other Income/Expenses
$ 282.00K$ 641.00K$ 204.00K$ 4.00K$ 31.00K
Pretax Income
$ -9.83M$ -9.29M$ -10.08M$ -7.44M$ -4.66M
Net Income
$ -9.83M$ -9.29M$ -10.08M$ -7.44M$ -4.66M
Per Share Metrics
Basic EPS
$ -3.05$ -3.14$ -3.49$ -5.97$ -18.83
Diluted EPS
$ -3.05$ -3.14$ -3.49$ -5.97$ -18.83
Weighted Average Shares Outstanding
3.22M 2.96M 472.00K 207.50K-
Weighted Average Shares Outstanding (Diluted)
3.22M 2.96M 472.17K 207.50K-
Currency in USD

Artelo Biosciences Earnings and Revenue History